Special Issue "Combination Therapies for Pancreatic Cancer: How to Make Comprehensive Progress?"
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 7497
We would like to invite you to submit either original research or review articles for this Special Issue on “Combination Therapies for Pancreatic Cancer: How to Make Progress?” The journal has an impact factor of 6.639, and you are receiving this letter as a personal invitation on behalf of one of the Editors.
This Special Issue will focus on the recent advances in the field of PDAC treatment, focusing on new combinations in systemic therapies in metastatic settings but also on combining loco-regional approaches. The topics will include, but are not limited to, advances in: (1) chemotherapy as a backbone for new combinations with anti-metabolic drugs; (2) the emergence of targeting BRCAness; (3) new immuno(chemo)therapeutic combinations for PDAC subtypes; (4) targeting the pancreatic tumor microenvironment; (5) the potential role of CDK 4/6; (6) potential partners for radiation therapy; (7) new combinational approaches in locally advanced tumors; and (8) precision medicine in PDAC: practical approaches.
Thank you for your consideration.
Prof. Dr. Jean Luc B. van Laethem
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- pancreatic cancer
- systemic therapy
- molecular-driven therapy
- new translational combinations